Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00339
Species: Homo sapiens
Position : chr2:60722300-60722700
Year: 2015
Title: BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  26375006
MONDO:
Tissue: Hematopoietic system
Tissue Ontology ID: UBERON:0002371
Cell Source: HUDEP-2
CVCL ID: CVCL_VI06
Cell Type: erythroid progenitor cell
Cell Ontology ID: CL:0000038
Experiment Type: Functional perturbation assay, Enhancer activity assay
High Throughput Method: ChIP-seq, RNA-seq, ATAC-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, ChIP-RT-qPCR
About Target Gene
Target gene : BCL11A
About TF
TF name : GATA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
GATA1 C-MYB transcription factor network pid 87
GATA1 Factors involved in megakaryocyte development and platelet production reactome 111
GATA1 IL3 netpath 84
GATA1 Notch-mediated HES/HEY network pid 48
GATA1 p73 transcription factor network pid 80
GATA1 Signaling events mediated by HDAC Class I pid 89
GATA1 Signaling events mediated by HDAC Class II pid 58
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01052 chr2:60718043-60725451 Colon colorectal carcinoma cell colorectal carcinoma
Expression of Target Genes for the Enhancer